Table 1.
Consequence of SCI or Opioid Administration |
Mechanisms Common to SCI and Opioid Administration | |
---|---|---|
Decreased locomotor function | Excitotoxic cell death | Increased extracellular glutamate |
Increased NMDAR activation | ||
Increased dynorphin levels | ||
Increased glial activation | Release glutamate, ATP, CGRP, pro-inflammatory cytokines, ROS, NO | |
Apoptosis | Initiated via activation of caspase-3, increased Bax and decreased Bcl-2 Causes release of pro-inflammatory cytokines | |
Pain development | Central sensitization | Increased NMDAR activation |
Increased extracellular glutamate | ||
OIH | Increased NMDAR activation | |
Increased glutamate availability | ||
Increased spinal dynorphin | ||
Increased glial activation | Release glutamate, ATP, CGRP, pro-inflammatory cytokines, ROS, NO, activation of MAPK pathways, TLR’s | |
Increased risk of infection | Immune suppression, HPA dysregulation | Decreased lymphocyte levels |
Mortality | Increased glial activation | Increased pro-inflammatory cytokines |